Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRestore Regulatory News (RST)

Share Price Information for Restore (RST)

Share Price is delayed by 15 minutes
Get Live Data
254.00    -1.00 (-0.39%)
Bid:
253.00
Ask:
255.00
Spread: 2.00 (0.791%)
Market Cap: £339.42m
RST Live PriceLast checked at - London Stock Exchange

Intraday Restore Share Chart

Acquisition

4 May 2022 07:00

RNS Number : 1863K
Restore PLC
04 May 2022
 

4 May 2022

 

Restore plc

("Restore" or the "Group" or "Company")

 

Strategic acquisition increases Restore Technology capability

 

 

Restore (AIM: RST), the UK's leading provider of digital and information management and secure lifecycle services, is pleased to announce that it acquired 100% of the share capital of Ultratec (Holdings) Limited ("Ultratec") on 3rd May 2022.

 

This investment represents a further milestone in the Group's strategic development of Restore Technology.

 

Ultratec is a highly regarded provider of secure data erasure and physical data destruction services, bespoke technology recycling solutions, hard drive parts supply and Data Centre focussed hardware maintenance services.

 

A key feature of the business are the innovative and proprietary software solutions, Genesis* and Nemesis*. Both these products deliver additional value by extending the life of hard drive technologies, improving re-use recovery rates and securely erasing data substantially faster than comparable software solutions. The business has around 70 staff based in two locations at Stevenage and Henlow.

 

For the year to 31st March 2022, Ultratec achieved a revenue of £7.6 million, generating a profit before tax of £1.2 million and had net assets of £1.8 million. The business is being acquired in cash for an enterprise value of £9.4 million. In addition to the additional technical capability provided by the Genesis and Nemesis technologies, the combination will further increase the scale of Restore Technology and achieve synergies across revenues and operations.

 

*Genesis was developed by Ultratec as a proprietary software and hardware appliance that securely erases data on various hard disk formats and will also reconstruct hard drives to make previously damaged hard drives useable again. The appliance includes cloud based software to ease deployment and is delivered with a subscription model with recuring revenues. Nemesis performs the same functionality as Genesis but with networking equipment which is a growing market with the increasing amounts of data on networking devices posing a security risk for organisations.

 

www.ultratec.co.uk/genesis

www.ultratestsolutions.com

 

CHARLES BLIGH, CEO, COMMENTED:

 

"I am delighted to welcome the team at Ultratec to the Group and we look forward to developing the business together as part of Restore Technology, our rapidly growing IT lifecycle services business.

 

The team at Ultratec have an excellent reputation in the sector with a specialist focus on hard drive and storage products from repair, erasure and resale. Their innovative Genesis and Nemesis technologies represent opportunities to further expand our capabilities in technology lifecycle services. I am excited about this acquisition and the opportunity it represents for our business."

 

 

For further information:

Restore plc

www.restoreplc.com

Charles Bligh, CEONeil Ritchie, CFO

+44 (0) 207 409 2420

Investec (Nominated Adviser and Joint Broker)

www.investec.com

Carlton Nelson

James Rudd

 

+44 (0) 207 597 5970

Canaccord Genuity (Joint Broker, Corporate Advisor))

www.canaccordgenuity.com

Max Hartley

Chris Robinson

 

+44 (0) 207 523 8000

Citi (Joint Broker)

www.citigroup.com

Stuart Field

Luke Spells

 

+44 (0) 207 986 4074

Buchanan Communications (PR enquiries)

www.buchanan.uk.com

Charles Ryland

Stephanie Whitmore

 

+44 (0) 207 466 5000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQSSAFMDEESEDI
Date   Source Headline
20th Jul 201812:33 pmRNSHolding(s) in Company
9th Jul 201812:35 pmRNSHolding(s) in Company
5th Jul 20184:11 pmRNSHolding(s) in Company
3rd Jul 201810:00 amRNSHolding(s) in Company
3rd Jul 20189:56 amRNSHolding(s) in Company
25th Jun 20183:43 pmRNSDirector/PDMR Shareholding
29th May 201812:23 pmRNSDirector/PDMR Shareholding
21st May 20183:19 pmRNSResult of AGM
21st May 20187:00 amRNSAGM Statement
1st May 20188:15 amRNSCompletion of Acquisition
26th Apr 20183:41 pmRNSExercise of Options
20th Apr 201812:02 pmRNSHolding(s) in Company
10th Apr 20184:43 pmRNSNotice of GM
10th Apr 201810:23 amRNSHolding(s) in Company
6th Apr 201811:50 amRNSDirector/PDMR Shareholding
5th Apr 201812:30 pmRNSDirector/PDMR Shareholding
29th Mar 201810:18 amRNSHolding(s) in Company
28th Mar 20181:24 pmRNSDirector/PDMR Shareholding
26th Mar 201811:55 amRNSDirector/PDMR Shareholding
26th Mar 20187:00 amRNSAcquisition
21st Mar 20185:05 pmRNSAnnual Report and Notice of AGM
13th Mar 20187:00 amRNSFinal Results
30th Jan 20187:00 amRNSYear End Trading Update
12th Jan 20181:09 pmRNSExercise of Options
11th Dec 20173:01 pmRNSExercise of Options
28th Nov 20177:00 amRNSAppointment of Chairman Designate
7th Nov 20173:55 pmRNSIssue of Equity - Replacement
7th Nov 201712:48 pmRNSIssue of Equity
5th Oct 20175:04 pmRNSHolding(s) in Company
3rd Oct 201710:12 amRNSDirector/PDMR Shareholding
25th Sep 20171:19 pmRNSDirector/PDMR Shareholding
20th Sep 201712:19 pmRNSHolding(s) in Company
19th Sep 201712:18 pmRNSExercise of Options
18th Sep 20179:54 amRNSHolding(s) in Company
13th Sep 20174:58 pmRNSHolding(s) in Company
12th Sep 201711:23 amRNSExercise of Options
11th Sep 20177:00 amRNSAcquisition
11th Sep 20177:00 amRNSHalf-year Report
15th Aug 20177:00 amRNSDirectorate Change
15th Aug 20177:00 amRNSAcquisition of Baxter Confidential Limited
25th Jul 20177:00 amRNSHalf Year Trading Update
15th Jun 20177:00 amRNSSite Visit
12th Jun 20175:19 pmRNSHolding(s) in Company
5th Jun 20172:52 pmRNSIssue of Equity
5th Jun 20171:29 pmRNSPDMR Shareholding
22nd May 20173:10 pmRNSResult of AGM
22nd May 20177:00 amRNSAGM Statement
18th May 20173:46 pmRNSHolding(s) in Company
5th May 20173:36 pmRNSIssue of Equity
2nd May 201712:52 pmRNSExercise of Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.